MagAssist
MagAssist is a Chinese medical device company developing mechanical circulatory support platforms — including extracorporeal artificial hearts, percutaneous VADs, ECMO, and organ transport systems — for hospitals and cardiovascular centers treating severe heart failure.
- Company typePrivate
- Founded2017
- HeadquartersSuzhou, China
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What MagAssist does
MagAssist (心擎医疗) is a Chinese medical device company founded in 2017 and headquartered in Suzhou, with additional offices in Shanghai and Beijing. The company develops mechanical circulatory support (MCS) devices for patients with severe heart failure, spanning an extracorporeal fully magnetically suspended artificial heart (MoyoAssist), a minimally invasive percutaneous ventricular assist device (NyokAssist-PVAD), a next-generation extracorporeal membrane oxygenation (ECMO) system, and a warm-blood organ transport platform. The underlying technology is built around a proprietary fully magnetically suspended rotor architecture, which eliminates mechanical contact in the pump to reduce hemolysis and thrombosis — a technical differentiator relative to older friction-based pump designs and a foundation that supports cross-product R&D synergies across the MCS portfolio.
The company targets tertiary and quaternary hospitals and specialized cardiovascular centers in China through a direct institutional sales motion, with field teams operating from its three-city footprint. MagAssist is recognized as a unicorn enterprise and has appeared on the Future Healthcare 100 List for five consecutive years. The company has raised approximately $93 million across three funding rounds between 2019 and 2021, with investors including HSG, Cenova, CH Innovations, Northern Light Venture Capital, Med-Fine Capital, and Guoqian Venture Capital. International expansion signals include platform presentations at ISMCS 2025 in Vienna. Multiple products remain in development, and revenue is not publicly disclosed.
Revenue mechanics are anchored in hardware sales of life-supporting medical devices to healthcare institutions, with pricing negotiated directly through hospital procurement. The business model is concentrated in a single narrow customer segment — Chinese cardiac surgery and heart failure management departments — creating moderate concentration risk but also sticky, multi-year enterprise relationships once a device platform is adopted. The 51–100 person organization is structured to support parallel clinical, regulatory, and commercial functions across the four product platforms.
MagAssist firmographics
Firmographics- Name
- MagAssist
- Legal name
- MagAssist
- Website
- https://magassist.com.cn
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MagAssist is a Chinese medical device company developing mechanical circulatory support platforms — including extracorporeal artificial hearts, percutaneous VADs, ECMO, and organ transport systems — for hospitals and cardiovascular centers treating severe heart failure.
- Ownership category
- akta.pro rank
MagAssist industry classification
Industry- Product category
- Cardiovascular Medical Devices (Mechanical Circulatory Support)
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro industry
- Mechanical Circulatory Support (VAD, IABP, ECMO)Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation)Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
Keywords
Where MagAssist is headquartered
LocationHeadquarters
- HQ city
- Suzhou
- HQ country
- China
- HQ region
- Asia
Offices3 records
Markets served
MagAssist business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: MagAssist generates revenue through the sale of life-supporting medical devices including artificial hearts, ECMO systems, and organ transport platforms to hospitals and healthcare institutions. As a hardware-intensive medtech company, revenue is primarily derived from direct product sales to healthcare providers.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
MagAssist product offering
Product offeringCore offering
MagAssist develops and manufactures mechanical circulatory support (MCS) medical devices centered on fully magnetically suspended rotor technology. Its current portfolio covers four platforms: MoyoAssist (extracorporeal full magnetic levitation artificial heart / VAD), NyokAssist-PVAD (minimally invasive interventional artificial heart / percutaneous ventricular assist device), a next-generation portable ECMO (extracorporeal membrane oxygenation) system, and a warm blood organ transport platform for transplant logistics. These devices are sold to hospitals and cardiovascular centers to support heart failure patients across bridge-to-recovery, bridge-to-transplant, destination therapy, acute cardiac/respiratory support, and organ preservation pathways.
Product overview
心擎医疗(MagAssist)从心衰领域出发,致力于构建多器官支持平台。公司产品组合 includes体外全磁悬浮人工心脏(MoyoAssist)、微创介入式人工心脏(NyokAssist-PVAD)、新一代体外膜肺氧合(ECMO)以及温血器官转运平台等,覆盖多种机械循环支持(MCS)应用场景。
Differentiator
Problem solved
Functional benefit
Brands
- MoyoAssist: Extracorporeal fully magnetic levitation artificial heart product line.
- NyokAssist
Products and services
- MoyoAssist (Extracorporeal Full Magnetic Levitation Artificial Heart) Ventricular assist device providing temporary mechanical circulatory support using full magnetic levitation to eliminate mechanical contact in the blood path, reducing blood trauma and thrombosis risk for heart failure patients in tertiary/quaternary hospitals.
- NyokAssist-PVAD (Minimally Invasive Interventional Artificial Heart / pVAD) Percutaneous ventricular assist device (pVAD) designed for minimally invasive implantation, providing short-term mechanical cardiac support for patients with acute heart failure or undergoing high-risk cardiac procedures.
- ECMO (Next-Generation Extracorporeal Membrane Oxygenation System) Portable next-generation extracorporeal membrane oxygenation system providing combined cardiac and respiratory life support for patients with severe cardiopulmonary failure, including use cases outside traditional ICU settings.
- Warm Blood Organ Transport Platform System for preserving and transporting donor organs in a warm, oxygenated, blood-perfused state during transit, intended to maintain organ viability and improve transplant logistics for hospitals and transplant programs.
Quantifiable outcome
- Listed on the Future Healthcare 100 List for 5 consecutive years, indicating sustained recognition as a leading innovative medical device company in China.
Companies that use MagAssist
Customer profileSegments1 record
Ideal customer profiles1 record
MagAssist technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
MagAssist partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
MagAssist competitors and assessment
Company assessmentBroad incumbents
- Abbott: Global medtech leader behind HeartMate 3 LVAD and CentriMag/ECMO systems; the dominant incumbent MagAssist competes against in mechanical circulatory support, with a far deeper clinical evidence base and installed base.
- Medtronic: Major cardiovascular device incumbent with historical HVAD program and ECMO offerings; competes with MagAssist across multiple MCS categories with global commercial reach.
Direct peers
- Abiomed (Johnson & Johnson MedTech): Developer of the Impella percutaneous ventricular assist device family; the most direct global competitor to MagAssist's NyokAssist pVAD in the minimally invasive interventional VAD segment.
- Terumo: Japanese medtech with established ECMO systems and heart failure therapies; directly comparable as a multi-product MCS/heart failure player with a global footprint that MagAssist aspires to build.
- Berlin Heart: Developer of extracorporeal ventricular assist devices (EXCOR) for pediatric and adult patients; the closest direct analog to MagAssist's MoyoAssist extracorporeal magnetic levitation artificial heart.
- SynCardia Systems: Manufacturer of the SynCardia Total Artificial Heart, a competing implantable mechanical circulatory support device; relevant peer as MagAssist extends toward permanent/destination therapy indications.
Emerging players
- CARMAT: French developer of a bioprosthetic total artificial heart; a thematic peer in next-generation mechanical heart replacement technology with similar long-horizon commercial and clinical challenges to MagAssist's artificial heart programs.
- Novoheart: Hong Kong-based developer of bioartificial hearts and heart-in-a-jar technology; comparable emerging player with a focus on novel cardiac support platforms, though concentrated in preclinical/research tools rather than commercial MCS devices.
- Breethe (alung technologies): Developer of portable ECMO systems; directly comparable as a next-generation portable ECMO player competing with MagAssist's next-generation ECMO product.
Regional players
- CH Biomedical (苏州同心医疗器械): Chinese domestic competitor developing the CH-VAD implantable left ventricular assist device; the most direct Chinese medtech peer to MagAssist in the domestic MCS market, sharing similar regulatory pathway and customer base.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
MagAssist social profiles
Digital presenceMagAssist financial estimates
Financial estimateRevenue estimate
Valuation estimate
MagAssist leadership team
Management profileNumber of profiles
Profiles2 records
MagAssist funding detail
Funding detailFunding overview
Funding rounds3 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MagAssist M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MagAssist
What does MagAssist do?
MagAssist develops and manufactures mechanical circulatory support (MCS) medical devices centered on fully magnetically suspended rotor technology. Its current portfolio covers four platforms: MoyoAssist (extracorporeal full magnetic levitation artificial heart / VAD), NyokAssist-PVAD (minimally invasive interventional artificial heart / percutaneous ventricular assist device), a next-generation portable ECMO (extracorporeal membrane oxygenation) system, and a warm blood organ transport platform for transplant logistics. These devices are sold to hospitals and cardiovascular centers to support heart failure patients across bridge-to-recovery, bridge-to-transplant, destination therapy, acute cardiac/respiratory support, and organ preservation pathways.
Is MagAssist a public or private company?
MagAssist is a private company. It is classified as venture growth investor backed and is currently operating.
When was MagAssist founded?
MagAssist was founded in 2017. It employs 11 to 50 people.
Where is MagAssist based?
MagAssist is headquartered in Suzhou, China, in the Asia region.
How does MagAssist make money?
One revenue line is on record: medical Device Sales.
Who are MagAssist's main competitors?
Broad incumbents on record are Abbott and Medtronic. Direct peers are Abiomed (Johnson & Johnson MedTech), Terumo, Berlin Heart and SynCardia Systems. Emerging players are CARMAT, Novoheart and Breethe (alung technologies). CH Biomedical (苏州同心医疗器械) is listed as a regional player.
Does MagAssist have an API?
No public API is recorded for MagAssist.
What industry is MagAssist in?
MagAssist's product category is Cardiovascular Medical Devices (Mechanical Circulatory Support). Its primary akta.pro industry code is HLAHAFAG, Mechanical Circulatory Support (VAD, IABP, ECMO), with a secondary code of HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation). Its NAICS code is 334510 and its SIC code is 3845.